A Taste of Wellness for Savoury and Snacks
Givaudan
Roche, the Swiss pharmaceutical giant, this week reported weaker than expected sales growth. This news, together with the statement that their respected chief financial officer, Henri Meier, is to retire caused shares in the company to drop sharply. Pharmaceutical sales grew by just 2 per cent to SFr8.9bn ($5.2bn) in the first half of this year compared to 12 per cent in 1999.